Drug Discovery Today delivers informed and highly current news and reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports. Coverage includes: High-throughput screening Combination chemistry and parallel synthesis Genomics Compound libraries - rational design, utilization and conservation Business strategy for innovation Therapeutic targets Virtual chemistry Bioinformatics Advances in key compound classes and therapeutic areas Novel theraputic approaches Prodrugs and other aspects of drug discovery. The magazine builds on the established and renowned commissioning and presentation skills of the Elsevier Trends programme to ensure accuracy, relevance, currency and clarity of content.